English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background  As is true for many other antibiotic-resistant Gram-negative pathogens, members of the  Burkholderia cepacia  complex (BCC) are currently being assessed for their susceptibility to phage therapy as an antimicrobial treatment. The objective of this study was to perform genomic and limited functional characterization of the novel BCC phage JG068 (vB_BceP_JG068).    Results  JG068 is a podovirus that forms large, clear plaques on  Burkholderia cenocepacia  K56-2. Host range analysis indicates that this phage can infect environmental, clinical, and epidemic isolates of  Burkholderia multivorans ,  B. cenocepacia ,  Burkholderia stabilis , and  Burkholderia dolosa , likely through interaction with the host lipopolysaccharide as a receptor. The JG068 chromosome is 41,604 base pairs (bp) in length and is flanked by 216 bp short direct terminal repeats. Gene expression originates from both host and phage promoters and is in the forward direction for all 49 open reading frames. The genome sequence shows similarity to  Ralstonia  phage ϕRSB1,  Caulobacter  phage Cd1, and uncharacterized genetic loci of blood disease bacterium R229 and  Burkholderia pseudomallei  1710b. CoreGenesUniqueGenes analysis indicates that JG068 belongs to the  Autographivirinae  subfamily and ϕKMV-like phages genus. Modules within the genome encode proteins involved in DNA-binding, morphogenesis, and lysis, but none associated with pathogenicity or lysogeny. Similar to the signal-arrest-release (SAR) endolysin of ϕKMV, inducible expression of the JG068 SAR endolysin causes lysis of  Escherichia coli  that is dependent on the presence of an N-terminal signal sequence. In an  in vivo  assay using the  Galleria mellonella  infection model, treatment of  B. cenocepacia  K56-2-infected larvae with JG068 results in a significant increase in larval survival.    Conclusions  As JG068 has a broad host range, does not encode virulence factors, is obligately lytic, and has activity against an epidemic  B. cenocepacia  strain  in vivo , this phage is a highly promising candidate for BCC phage therapy development.

Genomic characterization of JG068, a novel virulent podovirus active against Burkholderia cenocepacia